A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 7 shares of PACB stock, worth $9. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 11 36.36%
Holding current value
$9
Previous $108,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$3.52 - $9.59 $14 - $38
-4 Reduced 36.36%
7 $0
Q4 2023

May 06, 2024

BUY
$5.97 - $10.36 $23 - $41
4 Added 57.14%
11 $108,000
Q4 2023

Feb 05, 2024

BUY
$5.97 - $10.36 $65 - $113
11 New
11 $108,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $292M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Di Nuzzo Private Wealth, Inc. Portfolio

Follow Di Nuzzo Private Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Di Nuzzo Private Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Di Nuzzo Private Wealth, Inc. with notifications on news.